Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healtang Biotech is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of functional sugar alcohols and dietary fibers. The company is a major global supplier of Xylo-oligosaccharide (XOS), L-arabinose, and Xylitol, which are used extensively in the food, beverage, and pharmaceutical industries to promote gut health and manage blood sugar levels. Operating as a key subsidiary of the Futaste Group, Healtang leverages advanced fermentation and extraction technologies to provide high-purity ingredients. Their products are designed to address metabolic health concerns such as obesity and diabetes by providing low-glycemic alternatives to traditional sweeteners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healtang.